Human immunodeficiency virus-1 (HIV-1) in the vapors of surgical power instruments
β Scribed by Gregory K. Johnson; William S. Robinson
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 401 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
Cool vapors and aerosols produced by several common surgical power instruments and hot smoke plumes generated with electrocautery on known HIV-1 innoculated blood were gently bubbled through sterile viral culture media. Tissue culture cells were then added and cell infection was detected by the appearance of HIV-1 P-24 core antigen assayed by ELISA in the culture medium. HIV-1 was cultured from cool aerosols and vapors generated by a 30,000 RPM spinning router tip, an instrument similar to the Midas Rex and the Stryker oscillating bone saw. No infectious HIV-1 was detected in aerosols generated by a Valley Lab electrocautery or with a manual wound irrigation syringe known as a Travenol Uromatic irrigator. We have demonstrated that HIV-1 can remain viable in cool aerosols generated by certain surgical power tools and this raises the possibility of HIV transmission to medical personnel exposed to aerosols similarly generated during the care of HIV infected patients. Further work is required to determine whether such a risk exists but caution should be exercised by those exposed to aerosols generated during procedures on HIV-1 infected patients.
π SIMILAR VOLUMES
## Abstract For Abstract see ChemInform Abstract in Full Text.
Glutathione (GSH) levels are markedly depleted in patients infected with human immunodeficiency virus type 1 (HIV-1) and supplementation of media with high concentrations (5-20 mM) of lowmolecular weight thiols prevents HIV-1 replication in cultured cells. We were intrigued whether chemopreventive e
To determine the seroprevalence of human herpesvirus 8 (HHV8) among human immunodeficiency virus 1 (HIV-1)-positive (HIV-1 + ) and HIV-1-negative (HIV-1 -) populations in Japan, 276 HIV-1 + patients and 1,000 HIV-1 -blood donors were enrolled in this study. Antibodies against HHV8 latency-associated